ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2021

Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.

Wei-Ru Chiou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.